NASDAQ:SRTS Sensus Healthcare (SRTS) Stock Forecast, Price & News $2.91 -0.18 (-5.83%) (As of 03:02 PM ET) Add Compare Share Share Today's Range$2.90▼$3.0750-Day Range$2.62▼$5.2852-Week Range$2.29▼$15.25Volume109,900 shsAverage Volume238,718 shsMarket Capitalization$47.72 millionP/E Ratio7.86Dividend YieldN/APrice Target$12.33 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Sensus Healthcare MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside320.9% Upside$12.33 Price TargetShort InterestHealthy2.53% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$89,840 Bought Last QuarterProj. Earnings Growth925.00%From $0.04 to $0.41 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.92 out of 5 starsMedical Sector20th out of 981 stocksSurgical & Medical Instruments Industry1st out of 98 stocks 3.5 Analyst's Opinion Consensus RatingSensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.33, Sensus Healthcare has a forecasted upside of 320.9% from its current price of $2.93.Amount of Analyst CoverageSensus Healthcare has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.53% of the float of Sensus Healthcare has been sold short.Short Interest Ratio / Days to CoverSensus Healthcare has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sensus Healthcare has recently decreased by 26.72%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSensus Healthcare does not currently pay a dividend.Dividend GrowthSensus Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SRTS. Previous Next 2.0 News and Social Media Coverage News SentimentSensus Healthcare has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Sensus Healthcare this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for SRTS on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Sensus Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sensus Healthcare insiders have bought more of their company's stock than they have sold. Specifically, they have bought $89,840.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders16.36% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 36.25% of the stock of Sensus Healthcare is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Sensus Healthcare are expected to grow by 925.00% in the coming year, from $0.04 to $0.41 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensus Healthcare is 7.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.89.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensus Healthcare is 7.92, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 97.16.Price to Book Value per Share RatioSensus Healthcare has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Sensus Healthcare (NASDAQ:SRTS) StockSensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.Read More Receive SRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address SRTS Stock News HeadlinesJune 2, 2023 | americanbankingnews.comJohn Heinrich Buys 10,000 Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) StockMay 17, 2023 | finance.yahoo.comSensus Healthcare's SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet PatientsJune 8, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.May 13, 2023 | americanbankingnews.comJoseph C. Sardano Acquires 17,075 Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) StockMay 10, 2023 | americanbankingnews.comHC Wainwright Equities Analysts Lower Earnings Estimates for Sensus Healthcare, Inc. (NASDAQ:SRTS)May 8, 2023 | americanbankingnews.comSensus Healthcare (NASDAQ:SRTS) Price Target Cut to $10.00 by Analysts at HC WainwrightMay 7, 2023 | americanbankingnews.comSensus Healthcare (NASDAQ:SRTS) Given New $7.00 Price Target at Alliance Global PartnersMay 6, 2023 | finance.yahoo.comSensus Healthcare First Quarter 2023 Earnings: Misses ExpectationsJune 8, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.May 5, 2023 | msn.comHC Wainwright & Co. Reiterates Sensus Healthcare (SRTS) Buy RecommendationMay 4, 2023 | msn.comAlliance Global Partners Maintains Sensus Healthcare (SRTS) Buy RecommendationMay 3, 2023 | msn.comSensus Healthcare: Q1 Earnings InsightsMay 3, 2023 | finance.yahoo.comSensus Healthcare Reports First Quarter 2023 Financial ResultsMay 3, 2023 | finance.yahoo.comSensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Misses Revenue EstimatesMay 2, 2023 | finance.yahoo.comInvestors in Sensus Healthcare (NASDAQ:SRTS) have seen favorable returns of 87% over the past three yearsApril 29, 2023 | americanbankingnews.comHead to Head Review: Nuvectra (OTCMKTS:NVTRQ) and Sensus Healthcare (NASDAQ:SRTS)April 27, 2023 | benzinga.comSensus Healthcare Stock (NASDAQ:SRTS), DividendsApril 27, 2023 | finance.yahoo.comInteger (ITGR) Surpasses Q1 Earnings and Revenue EstimatesApril 25, 2023 | finance.yahoo.comSensus Healthcare to Host First Quarter 2023 Financial Results and Business Update Conference Call on Wednesday, May 3, 2023April 11, 2023 | finance.yahoo.comReturns On Capital Are A Standout For Sensus Healthcare (NASDAQ:SRTS)April 10, 2023 | americanbankingnews.comComparing Sensus Healthcare (NASDAQ:SRTS) & Nyxoah (NASDAQ:NYXH)March 26, 2023 | finance.yahoo.comSensus Healthcare, Inc.'s (NASDAQ:SRTS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?March 16, 2023 | finance.yahoo.comSensus Healthcare announces the Sensus Cloud™; Unveils New Features at American Academy of Dermatology (AAD) Annual Meeting in New Orleans March 17-19March 11, 2023 | benzinga.comSensus Healthcare Stock (NASDAQ:SRTS), Short Interest ReportMarch 11, 2023 | finance.yahoo.comAn Intrinsic Calculation For Sensus Healthcare, Inc. (NASDAQ:SRTS) Suggests It's 39% UndervaluedMarch 6, 2023 | finance.yahoo.comImplied Volatility Surging for Sensus Healthcare (SRTS) Stock OptionsFebruary 12, 2023 | finance.yahoo.comSensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2022 Earnings Call TranscriptSee More Headlines SRTS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SRTS Company Calendar Last Earnings5/03/2023Today6/08/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SRTS CUSIPN/A CIK1494891 Webwww.sensushealthcare.com Phone(561) 922-5808Fax561-948-2071Employees37Year FoundedN/APrice Target and Rating Average Stock Price Forecast$12.33 High Stock Price Forecast$20.00 Low Stock Price Forecast$7.00 Forecasted Upside/Downside+323.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.37 Trailing P/E Ratio7.86 Forward P/E Ratio72.75 P/E GrowthN/ANet Income$24.24 million Net Margins16.73% Pretax Margin22.82% Return on Equity13.49% Return on Assets11.37% Debt Debt-to-Equity RatioN/A Current Ratio7.96 Quick Ratio6.93 Sales & Book Value Annual Sales$44.53 million Price / Sales1.07 Cash Flow$0.73 per share Price / Cash Flow3.99 Book Value$2.89 per share Price / Book1.01Miscellaneous Outstanding Shares16,400,000Free Float13,714,000Market Cap$47.72 million OptionableNot Optionable Beta0.64 Key ExecutivesJoseph C. SardanoChairman & Chief Executive OfficerMichael J. SardanoPresident, Secretary & General CounselMagdalena MartinezChief Operating OfficerJavier RampollaChief Financial OfficerRuss PriceDirector-EngineeringKey CompetitorsPAVmedNASDAQ:PAVMGBSNYSE:GBSMinerva SurgicalNASDAQ:UTRSIceCure MedicalNASDAQ:ICCMIsorayNYSE:ISRView All CompetitorsInsiders & InstitutionsAmeriprise Financial Inc.Sold 104,539 shares on 5/22/2023Ownership: 0.739%Rockefeller Capital Management L.P.Bought 15,000 shares on 5/17/2023Ownership: 0.130%Geode Capital Management LLCBought 9,684 shares on 5/16/2023Ownership: 0.784%Susquehanna International Group LLPBought 14,900 shares on 5/16/2023Ownership: 0.000%Squarepoint Ops LLCBought 11,989 shares on 5/16/2023Ownership: 0.071%View All Insider TransactionsView All Institutional Transactions SRTS Stock - Frequently Asked Questions Should I buy or sell Sensus Healthcare stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRTS shares. View SRTS analyst ratings or view top-rated stocks. What is Sensus Healthcare's stock price forecast for 2023? 3 brokers have issued twelve-month target prices for Sensus Healthcare's stock. Their SRTS share price forecasts range from $7.00 to $20.00. On average, they predict the company's stock price to reach $12.33 in the next twelve months. This suggests a possible upside of 323.8% from the stock's current price. View analysts price targets for SRTS or view top-rated stocks among Wall Street analysts. How have SRTS shares performed in 2023? Sensus Healthcare's stock was trading at $7.42 at the start of the year. Since then, SRTS shares have decreased by 60.8% and is now trading at $2.91. View the best growth stocks for 2023 here. Are investors shorting Sensus Healthcare? Sensus Healthcare saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 326,900 shares, a drop of 26.7% from the April 30th total of 446,100 shares. Based on an average daily trading volume, of 241,800 shares, the days-to-cover ratio is currently 1.4 days. Approximately 2.5% of the company's stock are sold short. View Sensus Healthcare's Short Interest. When is Sensus Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our SRTS earnings forecast. How were Sensus Healthcare's earnings last quarter? Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its quarterly earnings data on Wednesday, May, 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.23. The business had revenue of $3.41 million for the quarter, compared to analysts' expectations of $9.24 million. Sensus Healthcare had a net margin of 16.73% and a trailing twelve-month return on equity of 13.49%. What ETF holds Sensus Healthcare's stock ? First Trust Dow Jones Select Microcap Index Fund holds 34,469 shares of SRTS stock, representing 0.12% of its portfolio. What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM). When did Sensus Healthcare IPO? (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. What is Sensus Healthcare's stock symbol? Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS." Who are Sensus Healthcare's major shareholders? Sensus Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (3.89%), Punch & Associates Investment Management Inc. (2.58%), Renaissance Technologies LLC (1.63%), Empirical Financial Services LLC d.b.a. Empirical Wealth Management (1.14%), Geode Capital Management LLC (0.78%) and Dimensional Fund Advisors LP (0.77%). Insiders that own company stock include Javier Rampolla, John Heinrich, Joseph C Sardano, Michael Sardano, Nicolas Soro, Samuel O'rear, Stephen Brad Cohen and William H Mccall. View institutional ownership trends. How do I buy shares of Sensus Healthcare? Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sensus Healthcare's stock price today? One share of SRTS stock can currently be purchased for approximately $2.91. How much money does Sensus Healthcare make? Sensus Healthcare (NASDAQ:SRTS) has a market capitalization of $47.72 million and generates $44.53 million in revenue each year. The company earns $24.24 million in net income (profit) each year or $0.37 on an earnings per share basis. How can I contact Sensus Healthcare? Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The official website for the company is www.sensushealthcare.com. The company can be reached via phone at (561) 922-5808, via email at kgolodetz@lhai.com, or via fax at 561-948-2071. This page (NASDAQ:SRTS) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.